Your browser doesn't support javascript.
loading
An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype.
Guan, Yun; Shen, Yunzhu; Xu, Ye; Li, Chao; Wang, Jingwen; Gu, Weilie; Lian, Peng; Huang, Dan; Cai, Sanjun; Zhang, Zhen; Zhu, Ji.
Affiliation
  • Guan Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Shen Y; Department of Oncology, Nanjing Medical University, Nanjing, China.
  • Xu Y; Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Li C; Department of Radiation Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Wang J; Department of Radiation Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Gu W; Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Lian P; Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Huang D; Department of Pathology, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Cai S; Department of Colorectal Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Zhang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Centre, No. 270, Dong'An Road, Shanghai 200032, China.
  • Zhu J; Department of Radiation Oncology, Fudan University Shanghai Cancer Centre, No. 270, Dong'An Road, Shanghai 200032, China.
Therap Adv Gastroenterol ; 12: 1756284819852293, 2019.
Article in En | MEDLINE | ID: mdl-31217818
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Therap Adv Gastroenterol Year: 2019 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Therap Adv Gastroenterol Year: 2019 Type: Article Affiliation country: China